Clinical trial ELEGANT
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence?A Global, Multicenter, Randomized, Open-label Phase 3 Study
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Stemline Therapeutics, Inc. |
| EudraCT Identifier | 2024-515445-42-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT06492616 |
| Last update |